Nexgel Inc (NXGL)

$1.15 0.00 (N/A)
Market Cap 9.37M
Revenue (ttm) 8.69M
Net Income (ttm) -3.28M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -37.74%
Debt to Equity Ratio 0.00
Volume 45,690
Avg Vol 43,768
Day's Range N/A - N/A
Shares Out 8.14M
Stochastic %K 13%
Beta 0.59
Analysts Strong Sell
Price Target $6.00

Company Profile

NEXGEL, Inc. manufactures and sells high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments: Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications; and beauty and cosmetic solutions. It also developing NEXDrape, an incise surgical drape designed for patients with impaired skin;...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 215 702 8550
Website: nexgel.com
Address:
2150 Cabot Boulevard West, Suite B, Langhorne, United States
OldManLogan
OldManLogan Mar. 2 at 12:45 PM
$NXGL Not a holder presently but ya, unless the "mystery acquisition " is some unknown gem of a business, then the company is contemplating something like 175% dilution for this acquisition, so really a reverse takeover. Should make people suspect Adam's enthusiasm for the company's own prospects...
0 · Reply
ksp1998
ksp1998 Feb. 24 at 9:10 AM
$NXGL to all those retail and institutional i nvestors, please write an email to CEO to reconsider recent convertible notes offering to an investor as per 424B5 filing for a pending acquisition. It is very dilutive to existing shareholders and will completely destroy the stock value overtime. It eventually will favor the note holder than existing shareholders since ipo. [email protected]
0 · Reply
PortfolioEssence
PortfolioEssence Feb. 20 at 1:59 PM
$NXGL NEXGEL develops wound-care and medical gel products. Revenue growth depends on distribution expansion. Margins improve with scale.
1 · Reply
BillionerOfKing
BillionerOfKing Feb. 19 at 1:40 PM
$NXGL Current Stock Price: $1.28
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 17 at 3:07 PM
$NXGL RSI: 38.19, MACD: -0.0842 Vol: 0.15, MA20: 1.42, MA50: 1.55 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
10baggerPete
10baggerPete Feb. 10 at 2:30 PM
$NXGL So an acquisition ? That would have been great in 2024 when the stock was up at $5 much when it's moving towards all time lows. Jokers.
0 · Reply
NVDAMillionaire
NVDAMillionaire Feb. 4 at 1:00 PM
$NXGL Brilliant piece that captures NXGL's situation perfectly. So if you want to update your understanding of NXGL or get to know NXGL better, this is essential reading. https://everyticker.com/quote/NXGL/analysis/nxgl-hydrogel-innovation-fuels-rapid-expansion-towards-profitability
0 · Reply
BillionerOfKing
BillionerOfKing Jan. 15 at 9:18 PM
$NXGL Current Stock Price: $1.75
0 · Reply
SuperGreenToday
SuperGreenToday Jan. 9 at 2:35 PM
$NXGL
0 · Reply
Dr_Monkeybreath
Dr_Monkeybreath Jan. 2 at 6:14 PM
$NXGL wish i'd bought more. 🤷‍♂️
1 · Reply
Latest News on NXGL
NEXGEL Announces Spin-Off of Drug Delivery Program into NexGelRx

Dec 11, 2025, 8:00 AM EST - 2 months ago

NEXGEL Announces Spin-Off of Drug Delivery Program into NexGelRx

NEXGEL, Inc. (NXGL) Q3 2025 Earnings Call Transcript

Nov 11, 2025, 9:51 PM EST - 3 months ago

NEXGEL, Inc. (NXGL) Q3 2025 Earnings Call Transcript

NEXGEL Reports Third Quarter 2025 Financial Results

Nov 11, 2025, 4:10 PM EST - 3 months ago

NEXGEL Reports Third Quarter 2025 Financial Results

NEXGEL, Inc. (NXGL) Q2 2025 Earnings Call Transcript

Aug 12, 2025, 7:47 PM EDT - 7 months ago

NEXGEL, Inc. (NXGL) Q2 2025 Earnings Call Transcript

NEXGEL to Report Second Quarter 2025 Financial Results on August 12th

Aug 6, 2025, 8:00 AM EDT - 7 months ago

NEXGEL to Report Second Quarter 2025 Financial Results on August 12th

NEXGEL Announces $950,000 Registered Direct Offering and Concurrent Private Placement

Aug 1, 2025, 8:00 AM EDT - 7 months ago

NEXGEL Announces $950,000 Registered Direct Offering and Concurrent Private Placement

NEXGEL and STADA AG Announce Expansion of Partnership for North America

Jul 14, 2025, 9:00 AM EDT - 8 months ago

NEXGEL and STADA AG Announce Expansion of Partnership for North America

NEXGEL, Inc. (NXGL) Q1 2025 Earnings Call Transcript

May 13, 2025, 10:43 PM EDT - 10 months ago

NEXGEL, Inc. (NXGL) Q1 2025 Earnings Call Transcript

NEXGEL to Report First Quarter 2025 Financial Results on May 13th

May 9, 2025, 9:00 AM EDT - 10 months ago

NEXGEL to Report First Quarter 2025 Financial Results on May 13th

NEXGEL, Inc. (NXGL) Q4 2024 Earnings Call Transcript

Mar 24, 2025, 5:41 PM EDT - 1 year ago

NEXGEL, Inc. (NXGL) Q4 2024 Earnings Call Transcript

NEXGEL Reports Record Fourth Quarter and Full Year 2024 Financial Results

Mar 24, 2025, 4:05 PM EDT - 1 year ago

NEXGEL Reports Record Fourth Quarter and Full Year 2024 Financial Results

NEXGEL to Report Fourth Quarter and Full Year 2024 Financial Results on March 24th

Mar 19, 2025, 9:00 AM EDT - 1 year ago

NEXGEL to Report Fourth Quarter and Full Year 2024 Financial Results on March 24th

NEXGEL to Participate in Webull Consumer Virtual Webinar on February 18, 2025

Feb 13, 2025, 9:00 AM EST - 1 year ago

NEXGEL to Participate in Webull Consumer Virtual Webinar on February 18, 2025

NEXGEL Appoints Joseph F. McGuire as Chief Financial Officer

Jan 2, 2025, 9:00 AM EST - 1 year ago

NEXGEL Appoints Joseph F. McGuire as Chief Financial Officer

NEXGEL, Inc. (NXGL) Q3 2024 Earnings Call Transcript

Nov 13, 2024, 10:56 PM EST - 1 year ago

NEXGEL, Inc. (NXGL) Q3 2024 Earnings Call Transcript

NEXGEL Reports Record Third Quarter 2024 Revenue of $2.94 Million, an Increase of 141% Year-Over-Year and 104% Sequentially

Nov 13, 2024, 4:40 PM EST - 1 year ago

NEXGEL Reports Record Third Quarter 2024 Revenue of $2.94 Million, an Increase of 141% Year-Over-Year and 104% Sequentially

NEXGEL Announces $2,000,000 Registered Direct Offering

Nov 11, 2024, 5:35 PM EST - 1 year ago

NEXGEL Announces $2,000,000 Registered Direct Offering

NEXGEL to Participate in Upcoming October Investor Conferences

Oct 11, 2024, 9:00 AM EDT - 1 year ago

NEXGEL to Participate in Upcoming October Investor Conferences

NEXGEL Appoints Kip Crecca to its Scientific Advisory Board

Oct 4, 2024, 9:00 AM EDT - 1 year ago

NEXGEL Appoints Kip Crecca to its Scientific Advisory Board

NEXGEL, Inc. (NXGL) Q2 2024 Earnings Call Transcript

Aug 14, 2024, 9:01 PM EDT - 1 year ago

NEXGEL, Inc. (NXGL) Q2 2024 Earnings Call Transcript

NEXGEL Reports Record Second Quarter 2024 Revenue of $1.44 Million

Aug 14, 2024, 4:25 PM EDT - 1 year ago

NEXGEL Reports Record Second Quarter 2024 Revenue of $1.44 Million

NEXGEL to Report Second Quarter 2024 Financial Results on August 14th

Aug 12, 2024, 9:15 AM EDT - 1 year ago

NEXGEL to Report Second Quarter 2024 Financial Results on August 14th

NEXGEL and Innovative Optics US Initiate Institutional Review Board (IRB) Study in Accordance with FDA of Hydrogel Application During Laser Hair Removal

Jul 18, 2024, 9:15 AM EDT - 1 year ago

NEXGEL and Innovative Optics US Initiate Institutional Review Board (IRB) Study in Accordance with FDA of Hydrogel Application During Laser Hair Removal

NEXGEL Announces Preliminary Record Second Quarter 2024 Revenue of $1.4 Million and Issues Revenue Guidance for Third and Fourth Quarter of 2024 of $2.2 Million and $2.6 Million, Respectively

Jul 8, 2024, 4:05 PM EDT - 1 year ago

NEXGEL Announces Preliminary Record Second Quarter 2024 Revenue of $1.4 Million and Issues Revenue Guidance for Third and Fourth Quarter of 2024 of $2.2 Million and $2.6 Million, Respectively

NEXGEL and STADA Partner to Launch Leading European DAO Enzyme Supplement, Histasolv, in North America

Jun 11, 2024, 8:40 AM EDT - 1 year ago

NEXGEL and STADA Partner to Launch Leading European DAO Enzyme Supplement, Histasolv, in North America

NEXGEL Acquires International Beauty Brand, Silly George

May 16, 2024, 9:00 AM EDT - 1 year ago

NEXGEL Acquires International Beauty Brand, Silly George

NEXGEL, Inc. (NXGL) Q1 2024 Earnings Call Transcript

May 13, 2024, 6:35 PM EDT - 1 year ago

NEXGEL, Inc. (NXGL) Q1 2024 Earnings Call Transcript

NEXGEL, Inc. (NXGL) Q4 2023 Earnings Call Transcript

Apr 1, 2024, 2:25 PM EDT - 2 years ago

NEXGEL, Inc. (NXGL) Q4 2023 Earnings Call Transcript

NEXGEL Reports Full Year 2023 Revenue of $4.1 Million, an Increase of 99.7% Year-Over-Year

Apr 1, 2024, 7:50 AM EDT - 2 years ago

NEXGEL Reports Full Year 2023 Revenue of $4.1 Million, an Increase of 99.7% Year-Over-Year

NEXGEL Reschedules Fourth Quarter and Full Year 2023 Financial Results Conference Call to Monday, April 1st at 8:30 a.m. ET Due to Holiday

Mar 27, 2024, 9:00 AM EDT - 2 years ago

NEXGEL Reschedules Fourth Quarter and Full Year 2023 Financial Results Conference Call to Monday, April 1st at 8:30 a.m. ET Due to Holiday

NEXGEL to Report Fourth Quarter and Full Year 2023 Financial Results on March 28th

Mar 21, 2024, 9:00 AM EDT - 2 years ago

NEXGEL to Report Fourth Quarter and Full Year 2023 Financial Results on March 28th

NEXGEL to Present at the iAccess Alpha Best Ideas Spring Virtual Conference on March 12th

Mar 4, 2024, 8:30 AM EST - 2 years ago

NEXGEL to Present at the iAccess Alpha Best Ideas Spring Virtual Conference on March 12th

NEXGEL Subsidiary, CG Converting and Packaging, Begins 12,000 Square Foot Expansion of Texas Facility to Support the Expected Growth in Product Demand in 2024

Jan 9, 2024, 8:30 AM EST - 2 years ago

NEXGEL Subsidiary, CG Converting and Packaging, Begins 12,000 Square Foot Expansion of Texas Facility to Support the Expected Growth in Product Demand in 2024

NEXGEL Announces Partnership with STADA to Distribute and Commercialize Consumer Health OTC Products in North America

Dec 11, 2023, 8:00 AM EST - 2 years ago

NEXGEL Announces Partnership with STADA to Distribute and Commercialize Consumer Health OTC Products in North America

NEXGEL, Inc. (NXGL) Q3 2023 Earnings Call Transcript

Nov 17, 2023, 2:27 PM EST - 2 years ago

NEXGEL, Inc. (NXGL) Q3 2023 Earnings Call Transcript

NEXGEL Reports Record Third Quarter 2023 Revenue of $1.2 Million, an Increase of 115% Year-Over-Year

Nov 13, 2023, 4:05 PM EST - 2 years ago

NEXGEL Reports Record Third Quarter 2023 Revenue of $1.2 Million, an Increase of 115% Year-Over-Year

NEXGEL to Participate in the LD Micro Main Event XVI on October 3rd

Sep 26, 2023, 9:49 AM EDT - 2 years ago

NEXGEL to Participate in the LD Micro Main Event XVI on October 3rd

NEXGEL, Inc. (NXGL) Q2 2023 Earnings Call Transcript

Aug 17, 2023, 6:01 PM EDT - 2 years ago

NEXGEL, Inc. (NXGL) Q2 2023 Earnings Call Transcript

NEXGEL to Report Second Quarter 2023 Financial Results on August 14th

Aug 2, 2023, 9:00 AM EDT - 2 years ago

NEXGEL to Report Second Quarter 2023 Financial Results on August 14th

NEXGEL Partners with Enigma Health to Distribute its Leading Products in Retail Stores throughout North America

Jul 19, 2023, 9:10 AM EDT - 2 years ago

NEXGEL Partners with Enigma Health to Distribute its Leading Products in Retail Stores throughout North America

NEXGEL to Participate in Maxim Group's Virtual Healthcare Conference on June 20th

Jun 15, 2023, 9:00 AM EDT - 2 years ago

NEXGEL to Participate in Maxim Group's Virtual Healthcare Conference on June 20th

NEXGEL to Participate in the LD Micro Invitational XIII on June 6th

May 24, 2023, 9:00 AM EDT - 3 years ago

NEXGEL to Participate in the LD Micro Invitational XIII on June 6th

NEXGEL to Report First Quarter 2023 Financial Results on May 15th

May 9, 2023, 9:15 AM EDT - 3 years ago

NEXGEL to Report First Quarter 2023 Financial Results on May 15th

NEXGEL Reports Fourth Quarter and Full Year 2022 Financial Results

Mar 27, 2023, 4:05 PM EDT - 3 years ago

NEXGEL Reports Fourth Quarter and Full Year 2022 Financial Results

NEXGEL to Report Fourth Quarter and Full Year 2022 Financial Results on March 27th

Mar 15, 2023, 7:30 AM EDT - 3 years ago

NEXGEL to Report Fourth Quarter and Full Year 2022 Financial Results on March 27th

NEXGEL Partners with Former Major League Lacrosse Player, Greg “The Beast” Gurenlian, and The Face-Off Academy to Fight Turf Burn with Turfguard

Mar 7, 2023, 7:30 AM EST - 3 years ago

NEXGEL Partners with Former Major League Lacrosse Player, Greg “The Beast” Gurenlian, and The Face-Off Academy to Fight Turf Burn with Turfguard

NEXGEL Acquires 50% Interest in Newly Formed Joint Venture with C.G. Laboratories for Converting and Packaging Business

Mar 2, 2023, 8:30 AM EST - 3 years ago

NEXGEL Acquires 50% Interest in Newly Formed Joint Venture with C.G. Laboratories for Converting and Packaging Business

NEXGEL Appoints Scott Henry, CFA to Board of Directors and Audit Committee

Jan 17, 2023, 7:30 AM EST - 3 years ago

NEXGEL Appoints Scott Henry, CFA to Board of Directors and Audit Committee

NEXGEL Launches Turfguard to Treat Painful Turf Burns and Protect Sports-Related Wounds

Dec 8, 2022, 7:30 AM EST - 3 years ago

NEXGEL Launches Turfguard to Treat Painful Turf Burns and Protect Sports-Related Wounds

NEXGEL Announces Share Repurchase Program

Dec 7, 2022, 7:30 AM EST - 3 years ago

NEXGEL Announces Share Repurchase Program

OldManLogan
OldManLogan Mar. 2 at 12:45 PM
$NXGL Not a holder presently but ya, unless the "mystery acquisition " is some unknown gem of a business, then the company is contemplating something like 175% dilution for this acquisition, so really a reverse takeover. Should make people suspect Adam's enthusiasm for the company's own prospects...
0 · Reply
ksp1998
ksp1998 Feb. 24 at 9:10 AM
$NXGL to all those retail and institutional i nvestors, please write an email to CEO to reconsider recent convertible notes offering to an investor as per 424B5 filing for a pending acquisition. It is very dilutive to existing shareholders and will completely destroy the stock value overtime. It eventually will favor the note holder than existing shareholders since ipo. [email protected]
0 · Reply
PortfolioEssence
PortfolioEssence Feb. 20 at 1:59 PM
$NXGL NEXGEL develops wound-care and medical gel products. Revenue growth depends on distribution expansion. Margins improve with scale.
1 · Reply
BillionerOfKing
BillionerOfKing Feb. 19 at 1:40 PM
$NXGL Current Stock Price: $1.28
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 17 at 3:07 PM
$NXGL RSI: 38.19, MACD: -0.0842 Vol: 0.15, MA20: 1.42, MA50: 1.55 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
10baggerPete
10baggerPete Feb. 10 at 2:30 PM
$NXGL So an acquisition ? That would have been great in 2024 when the stock was up at $5 much when it's moving towards all time lows. Jokers.
0 · Reply
NVDAMillionaire
NVDAMillionaire Feb. 4 at 1:00 PM
$NXGL Brilliant piece that captures NXGL's situation perfectly. So if you want to update your understanding of NXGL or get to know NXGL better, this is essential reading. https://everyticker.com/quote/NXGL/analysis/nxgl-hydrogel-innovation-fuels-rapid-expansion-towards-profitability
0 · Reply
BillionerOfKing
BillionerOfKing Jan. 15 at 9:18 PM
$NXGL Current Stock Price: $1.75
0 · Reply
SuperGreenToday
SuperGreenToday Jan. 9 at 2:35 PM
$NXGL
0 · Reply
Dr_Monkeybreath
Dr_Monkeybreath Jan. 2 at 6:14 PM
$NXGL wish i'd bought more. 🤷‍♂️
1 · Reply
OldManLogan
OldManLogan Jan. 2 at 6:04 PM
$NXGL This got too cheap to ignore in the $1.50S and $1.60S...
2 · Reply
pennypincher64
pennypincher64 Dec. 22 at 10:01 PM
$NXGL What a piece of garbage
0 · Reply
pennypincher64
pennypincher64 Dec. 17 at 9:09 PM
$NXGL Something is cooking. Look at that run last 5 minutes. Need alot more of that but lets see
1 · Reply
moonbagbilly
moonbagbilly Dec. 11 at 2:04 PM
$NXGL
0 · Reply
Shareholdersunite
Shareholdersunite Dec. 11 at 12:07 PM
$NXGL NEXGEL, down but not out, a setback from AbbVie and difficult comps mask underlying growth.. https://open.substack.com/pub/shareholdersunite/p/nexgel-down-but-certainly-not-out?r=1qzep5&utm_campaign=post&utm_medium=web&showWelcomeOnShare=true
0 · Reply
Dr_Monkeybreath
Dr_Monkeybreath Nov. 28 at 5:59 PM
$NXGL 1,000 @ $1.82.🔒
1 · Reply
TPower
TPower Nov. 25 at 12:10 PM
$NXGL On November 21, 2025, NEXGEL, INC. Board cancelled a Special Meeting planned for November 26, 2025, which was intended to discuss increasing authorized shares from 25 million to 1 billion.
1 · Reply
OldManLogan
OldManLogan Nov. 24 at 10:25 PM
$NXGL Back to 2022 prices, wow. Moved to "close watch "
0 · Reply